Epithalon (Epitalon) Research Overview

Epithalon, also written Epitalon, is a synthetic tetrapeptide with the sequence alanyl-glutamyl-aspartyl-glycine (Ala-Glu-Asp-Gly), commonly abbreviated AEDG.

It is studied in the context of experimental aging research, particularly in relation to telomere biology and the enzyme telomerase. It is not an approved medicine in the United States.

Epithalon originated from Soviet and later Russian research on pineal gland extracts, notably a preparation called epithalamin. Researchers there proposed that short peptide sequences were responsible for observed effects and synthesized AEDG as a defined four-amino-acid construct.

Most of the published Epithalon literature comes from this research tradition, and a large share of it appears in a small number of Russian journals. Independent replication outside that tradition is limited, which is a significant consideration when evaluating the evidence.

The most cited proposed mechanism concerns telomerase — an enzyme that adds repetitive DNA sequences to the ends of chromosomes, counteracting the shortening that occurs with cell division. Cell-culture reports have described increased telomerase activity and telomere length in treated human somatic cell lines.

Other proposed mechanisms include effects on gene expression and on melatonin-related pineal function in animals. These remain proposals; the molecular route by which a four-amino-acid peptide would produce such effects has not been definitively established.

Some work has examined direct interactions between short peptides and DNA sequences, a hypothesis advanced within the same research tradition and not broadly confirmed elsewhere.

Telomere and telomerase biology in cultured human cells.

Aging biology in rodents, including lifespan and biomarker studies.

Pineal and circadian research, including melatonin rhythm measures in animals.

Gene expression studies in experimental systems.

The telomerase findings derive from in-vitro experiments with cultured cell lines. Increased telomerase activity in a cell line is a measurement about that culture, not a demonstration of any organism-level outcome.

Rodent studies reporting effects on lifespan-related measures exist, primarily from the originating research groups.

Controlled human clinical trial evidence is essentially absent. Claims of anti-aging or longevity effects in people are not supported by the published record, and should not be inferred from cell or rodent results.

Concentration of the literature within a single research tradition, with limited independent replication.

Language and indexing barriers that make critical appraisal of older reports difficult.

Unresolved mechanism: how a tetrapeptide would influence telomerase expression has not been established.

No meaningful human clinical trial data and no long-term human safety evidence.

Epithalon is the synthetic AEDG tetrapeptide developed from Russian pineal peptide research.

Telomerase-related cell-culture findings and rodent aging studies form the core of its literature.

Evidence is preliminary, largely from one research tradition, and provides no basis for longevity claims in humans.

This page is provided for scientific and educational purposes only. It summarizes published laboratory research and does not constitute medical advice, does not describe any approved therapy, and does not provide instructions for human use of any kind.

SFVLAB supplies this compound strictly as a research-use-only material for laboratory investigation.